John E. Lynch

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About John E. Lynch

Earlier roles on record: Board Member at IGC Pharma, Inc. (IGC) until December 24, 2022. IGC Pharma, Inc. reported in an 8-K filed December 29, 2022 that John E. Lynch was terminated as Director, effective December 24, 2022.

“On December 24, 2022, John E. Lynch, a Director of India Globalization Capital Inc. (the "Company" or "IGC"), passed away.”

IGC Pharma, Inc. Form 8-K, filed December 29, 2022 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Research with Equibles

Turn this profile into a cited research brief

Start with a question tailored to the filings and events on this page, or connect Equibles financial data to ChatGPT or Claude.

Suggested question: “Summarize John E. Lynch's recent executive appointments or departures and cite the source filings.”

Use in your AI

Affiliation history

Recorded current and former roles; source labels appear when available.

IGC Pharma, Inc. (IGC)
Board Member

SEC 8-K

2021-01-11–2022-12-24
IGC Pharma, Inc. (IGC)
Board Member

Proxy statement

Start not stated–2022-12-24

Company network

Recorded roles and call appearances connecting this person to public companies.

IGC Pharma, Inc.

IGC

Board Member

2021-01-11–2022-12-24

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.

Executive change Terminated: Director IGC Pharma, Inc. (IGC)
2022-12-24